ARCT
Price
$9.48
Change
-$0.72 (-7.06%)
Updated
Apr 3, 04:59 PM (EDT)
Capitalization
276.62M
39 days until earnings call
BMEA
Price
$1.98
Change
-$0.18 (-8.33%)
Updated
Apr 3, 02:31 PM (EDT)
Capitalization
78.28M
27 days until earnings call
Ad is loading...

ARCT vs BMEA

Header iconARCT vs BMEA Comparison
Open Charts ARCT vs BMEABanner chart's image
Arcturus Therapeutics Holdings
Price$9.48
Change-$0.72 (-7.06%)
Volume$5.19K
Capitalization276.62M
Biomea Fusion
Price$1.98
Change-$0.18 (-8.33%)
Volume$200
Capitalization78.28M
ARCT vs BMEA Comparison Chart
Loading...
ARCT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
BMEA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ARCT vs. BMEA commentary
Apr 03, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ARCT is a Hold and BMEA is a Hold.

Ad is loading...
COMPARISON
Comparison
Apr 03, 2025
Stock price -- (ARCT: $10.20 vs. BMEA: $2.16)
Brand notoriety: ARCT and BMEA are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ARCT: 142% vs. BMEA: 153%
Market capitalization -- ARCT: $276.62M vs. BMEA: $78.28M
ARCT [@Biotechnology] is valued at $276.62M. BMEA’s [@Biotechnology] market capitalization is $78.28M. The market cap for tickers in the [@Biotechnology] industry ranges from $308.32B to $0. The average market capitalization across the [@Biotechnology] industry is $2.21B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ARCT’s FA Score shows that 0 FA rating(s) are green whileBMEA’s FA Score has 1 green FA rating(s).

  • ARCT’s FA Score: 0 green, 5 red.
  • BMEA’s FA Score: 1 green, 4 red.
According to our system of comparison, both ARCT and BMEA are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ARCT’s TA Score shows that 4 TA indicator(s) are bullish while BMEA’s TA Score has 4 bullish TA indicator(s).

  • ARCT’s TA Score: 4 bullish, 5 bearish.
  • BMEA’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, BMEA is a better buy in the short-term than ARCT.

Price Growth

ARCT (@Biotechnology) experienced а -14.64% price change this week, while BMEA (@Biotechnology) price change was -14.29% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -8.57%. For the same industry, the average monthly price growth was -10.69%, and the average quarterly price growth was -14.76%.

Reported Earning Dates

ARCT is expected to report earnings on May 12, 2025.

BMEA is expected to report earnings on Apr 30, 2025.

Industries' Descriptions

@Biotechnology (-8.57% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ARCT($277M) has a higher market cap than BMEA($78.3M). ARCT YTD gains are higher at: -39.894 vs. BMEA (-44.330). ARCT has higher annual earnings (EBITDA): -77.4M vs. BMEA (-149.62M). ARCT has more cash in the bank: 237M vs. BMEA (88M). BMEA has less debt than ARCT: BMEA (9.57M) vs ARCT (28.6M). ARCT has higher revenues than BMEA: ARCT (138M) vs BMEA (0).
ARCTBMEAARCT / BMEA
Capitalization277M78.3M354%
EBITDA-77.4M-149.62M52%
Gain YTD-39.894-44.33090%
P/E RatioN/AN/A-
Revenue138M0-
Total Cash237M88M269%
Total Debt28.6M9.57M299%
FUNDAMENTALS RATINGS
ARCT: Fundamental Ratings
ARCT
OUTLOOK RATING
1..100
55
VALUATION
overvalued / fair valued / undervalued
1..100
49
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
96
PRICE GROWTH RATING
1..100
96
P/E GROWTH RATING
1..100
99
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
ARCTBMEA
RSI
ODDS (%)
Bullish Trend 2 days ago
84%
Bullish Trend 2 days ago
76%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
75%
Bullish Trend 2 days ago
78%
Momentum
ODDS (%)
Bearish Trend 2 days ago
85%
Bearish Trend 2 days ago
86%
MACD
ODDS (%)
Bearish Trend 7 days ago
87%
Bearish Trend 2 days ago
87%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
87%
Bearish Trend 2 days ago
90%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
86%
Bearish Trend 2 days ago
90%
Advances
ODDS (%)
Bullish Trend 11 days ago
82%
Bullish Trend 14 days ago
82%
Declines
ODDS (%)
Bearish Trend 3 days ago
86%
Bearish Trend 3 days ago
90%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
90%
Bullish Trend 2 days ago
88%
Aroon
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
90%
View a ticker or compare two or three
Ad is loading...
ARCT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
BMEA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
DNNGY14.920.47
+3.25%
Orsted A/S
FARM2.250.04
+1.81%
Farmer Brothers Company
MEGEF17.60-0.04
-0.23%
Meg Energy Corp.
EBKDY34.82-0.10
-0.29%
Erste Group Bank AG
FFMGF0.09N/A
-2.16%
First Mining Gold Corp.

BMEA and

Correlation & Price change

A.I.dvisor indicates that over the last year, BMEA has been loosely correlated with ARCT. These tickers have moved in lockstep 50% of the time. This A.I.-generated data suggests there is some statistical probability that if BMEA jumps, then ARCT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BMEA
1D Price
Change %
BMEA100%
+8.54%
ARCT - BMEA
50%
Loosely correlated
+8.17%
BAIVF - BMEA
32%
Poorly correlated
N/A
KROS - BMEA
31%
Poorly correlated
+5.13%
IDYA - BMEA
30%
Poorly correlated
+10.70%
PRME - BMEA
30%
Poorly correlated
+0.28%
More